<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03640936</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-ASM-2014-66</org_study_id>
    <nct_id>NCT03640936</nct_id>
  </id_info>
  <brief_title>Total IgE (Immunoglobulin E) and Der p 1 (d1) Specific IgE in Induced Sputum in Patients With Allergic and Non-allergic Asthma</brief_title>
  <official_title>Total IgE and Der p 1 (d1) Specific IgE in Induced Sputum in Patients With Allergic and Non-allergic Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Asthma is a heterogeneous disease, and specifically the phenotype of non-allergic asthma is
      not yet well defined. Several studies describe this group of patients as having severe
      asthma, persistent eosinophilia and poor therapeutic response. Among the theories being
      considered is the role of local IgE. Objectives: 1) To perform a pilot test to validate the
      measurement technique and standardize the levels of total IgE and IgE specific to
      Dermatophagoides pteronyssinus (d1) in the induced sputum of asthmatic patients and healthy
      volunteers. 2) Correlate local total IgE and specific IgE levels to d1 (sputum and peripheral
      blood) in patients with allergic and non-allergic asthma. 3) Describe the clinical and
      inflammatory characteristics of patients with allergic and non-allergic asthma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparative cross-sectional study. It will include 32 allergic and non-allergic asthma
      patients and 10 healthy volunteers. All patients will have an induced sputum, pulmonary
      function studies, FENO (exhaled fraction of nitric oxide), total and specific IgE measurement
      at d1 (the most common perennial pneumoallergen) in blood and induced sputum, as well as a
      prick skin test with standardized allergen extracts. Measurement of total IgE and IgE for d1
      in induced sputum will be performed in the supernatant and by the ImmunoCAP (Phadia
      ThermoFisher Scientific) immunofluoroassay technique.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">February 1, 2019</completion_date>
  <primary_completion_date type="Actual">February 1, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Levels of specific IgE</measure>
    <time_frame>8 months</time_frame>
    <description>Detection of high levels or not of specific IgE in induced sputum</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Levels of total IgE</measure>
    <time_frame>8 months</time_frame>
    <description>Detection of high levels or not of total IgE in induced sputum</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">32</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <description>Healthy controls, without asthma or allergy (negative prick test)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Allergic asthma</arm_group_label>
    <description>Patients with allergic asthma sensitized to Dermatophagoides pteronyssinus, tested by prick test or specific IgE</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-allergic asthma</arm_group_label>
    <description>Patients with asthma not sensitized to Dermatophagoides pteronyssinus, with negative prick test or specific IgE</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Induced Sputum</intervention_name>
    <description>Total IgE and Specific IgE to Dermatophagoides pteronyssinus in Induced Sputum</description>
    <arm_group_label>Allergic asthma</arm_group_label>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_label>Non-allergic asthma</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Supernatant of induced sputum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed with asthma without evidence of allergic disease.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-70

          -  Asthma according to GEMA (spanish asthma guideline)

        Exclusion Criteria:

          -  Pregnancy

          -  Active smoking

          -  Moderate alcohol consumption

          -  Atopic dermatitis

          -  Other respiratory disease different than asthma (COPD, bronchiectasis, cystic
             fibrosis, pleural disease, interstitial disease)

          -  Treatment with steroids or inmunodepressants

          -  Active malignancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau. Carrer Mas Casanovas 90.</name>
      <address>
        <city>Barcelona</city>
        <zip>08041</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://www.gemasma.com.</url>
    <description>Spanish guideline of Asthma</description>
  </link>
  <reference>
    <citation>Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Ortega Martell JA, Platts-Mills TA, Ring J, Thien F, Van Cauwenberge P, Williams HC. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004 May;113(5):832-6.</citation>
    <PMID>15131563</PMID>
  </reference>
  <reference>
    <citation>Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012 May 4;18(5):716-25. doi: 10.1038/nm.2678. Review.</citation>
    <PMID>22561835</PMID>
  </reference>
  <reference>
    <citation>Crespo A, Giner J, Torrejón M, Belda A, Mateus E, Granel C, Torrego A, Ramos-Barbón D, Plaza V. Clinical and inflammatory features of asthma with dissociation between fractional exhaled nitric oxide and eosinophils in induced sputum. J Asthma. 2016 Jun;53(5):459-64. doi: 10.3109/02770903.2015.1116086. Epub 2016 Jan 19.</citation>
    <PMID>26785727</PMID>
  </reference>
  <reference>
    <citation>Rondón C, Campo P, Zambonino MA, Blanca-Lopez N, Torres MJ, Melendez L, Herrera R, Guéant-Rodriguez RM, Guéant JL, Canto G, Blanca M. Follow-up study in local allergic rhinitis shows a consistent entity not evolving to systemic allergic rhinitis. J Allergy Clin Immunol. 2014 Apr;133(4):1026-31. doi: 10.1016/j.jaci.2013.10.034. Epub 2013 Dec 13.</citation>
    <PMID>24332860</PMID>
  </reference>
  <reference>
    <citation>Baba S, Kondo K, Toma-Hirano M, Kanaya K, Suzukawa K, Ushio M, Suzukawa M, Ohta K, Yamasoba T. Local increase in IgE and class switch recombination to IgE in nasal polyps in chronic rhinosinusitis. Clin Exp Allergy. 2014;44(5):701-12. doi: 10.1111/cea.12287.</citation>
    <PMID>24931597</PMID>
  </reference>
  <reference>
    <citation>Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, Dolovich J. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 1992 Jan;47(1):25-9.</citation>
    <PMID>1539140</PMID>
  </reference>
  <reference>
    <citation>Margarit G, Belda J, Juárez C, Martínez C, Ramos A, Torrejón M, Granel C, Casán P, Sanchís J. [Total IgE in the sputum and serum of patients with asthma]. Allergol Immunopathol (Madr). 2005 Jan-Feb;33(1):48-53. Spanish.</citation>
    <PMID>15777524</PMID>
  </reference>
  <reference>
    <citation>Korn S, Haasler I, Fliedner F, Becher G, Strohner P, Staatz A, Taube C, Buhl R. Monitoring free serum IgE in severe asthma patients treated with omalizumab. Respir Med. 2012 Nov;106(11):1494-500. doi: 10.1016/j.rmed.2012.07.010. Epub 2012 Aug 11.</citation>
    <PMID>22884459</PMID>
  </reference>
  <reference>
    <citation>Vega JM, Badia X, Badiola C, López-Viña A, Olaguíbel JM, Picado C, Sastre J, Dal-Ré R; Covalair Investigator Group. Validation of the Spanish version of the Asthma Control Test (ACT). J Asthma. 2007 Dec;44(10):867-72.</citation>
    <PMID>18097865</PMID>
  </reference>
  <reference>
    <citation>Plaza Moral V; Comité Ejecutivo de GEMA. [GEMA(4.0). Guidelines for Asthma Management]. Arch Bronconeumol. 2015 Jan;51 Suppl 1:2-54. doi: 10.1016/S0300-2896(15)32812-X. Epub 2015 Nov 30. Spanish.</citation>
    <PMID>26707419</PMID>
  </reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>August 17, 2018</study_first_submitted>
  <study_first_submitted_qc>August 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 21, 2018</study_first_posted>
  <last_update_submitted>July 11, 2019</last_update_submitted>
  <last_update_submitted_qc>July 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>asthma</keyword>
  <keyword>allergy</keyword>
  <keyword>specific IgE</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

